The Role of Modification of the Original Ozaki Technique in the Treatment of Aortic Valve Diseases
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F20%3A43920911" target="_blank" >RIV/00216208:11120/20:43920911 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.33678/cor.2020.048" target="_blank" >https://doi.org/10.33678/cor.2020.048</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.33678/cor.2020.048" target="_blank" >10.33678/cor.2020.048</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The Role of Modification of the Original Ozaki Technique in the Treatment of Aortic Valve Diseases
Popis výsledku v původním jazyce
The aim of this pilot study is to present our one-year experience with the modification of the original Ozaki procedure for patients with an aortic valve stenosis and aortic valve infective endocarditis. Thirteen patients at the age of 70.5 +/- 10 (women/men: 8/5) underwent a replacement of the aortic valve using autologous or heterologous equinus pericardium. The indication for surgery was aortic valve stenosis (n = 10) or aortic valve regurgitation due to infective endocarditis (n = 3). Concomitant MAZE procedure (n = 2), aortocoronary bypass (n = 1), and left ventricular outflow tract myectomy (n = 1) were performed in four patients. One patient refused blood transfusion for religious reasons. The duration of cardiopulmonary bypass was 117.5 +/- 14.5 minutes and the X-clamp time was 107.0 +/- 14.4 minutes. The mean gradient after surgery was 5.1 +/- 1.9 mmHg; the peak gradient was 5.8 +/- 2.0 mmHg; the aortic valve area was 3.3 +/- 0.5 cm(2) and aortic valve regurgitation was 0.3 +/- 0.2. No 30-day mortality and no redo surgery due to valve failure were recorded. One patient died three months after surgery due to non-valve-related reasons. The modified Ozaki technique is a potentially effective alternative for younger patients rejecting anticoagulant medications and requiring aortic valve surgery. The preferred target group of patients for the use of this technique are those with a small aortic annulus and those with active infectious endocarditis.
Název v anglickém jazyce
The Role of Modification of the Original Ozaki Technique in the Treatment of Aortic Valve Diseases
Popis výsledku anglicky
The aim of this pilot study is to present our one-year experience with the modification of the original Ozaki procedure for patients with an aortic valve stenosis and aortic valve infective endocarditis. Thirteen patients at the age of 70.5 +/- 10 (women/men: 8/5) underwent a replacement of the aortic valve using autologous or heterologous equinus pericardium. The indication for surgery was aortic valve stenosis (n = 10) or aortic valve regurgitation due to infective endocarditis (n = 3). Concomitant MAZE procedure (n = 2), aortocoronary bypass (n = 1), and left ventricular outflow tract myectomy (n = 1) were performed in four patients. One patient refused blood transfusion for religious reasons. The duration of cardiopulmonary bypass was 117.5 +/- 14.5 minutes and the X-clamp time was 107.0 +/- 14.4 minutes. The mean gradient after surgery was 5.1 +/- 1.9 mmHg; the peak gradient was 5.8 +/- 2.0 mmHg; the aortic valve area was 3.3 +/- 0.5 cm(2) and aortic valve regurgitation was 0.3 +/- 0.2. No 30-day mortality and no redo surgery due to valve failure were recorded. One patient died three months after surgery due to non-valve-related reasons. The modified Ozaki technique is a potentially effective alternative for younger patients rejecting anticoagulant medications and requiring aortic valve surgery. The preferred target group of patients for the use of this technique are those with a small aortic annulus and those with active infectious endocarditis.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30201 - Cardiac and Cardiovascular systems
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Cor et Vasa
ISSN
0010-8650
e-ISSN
—
Svazek periodika
62
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
4
Strana od-do
547-550
Kód UT WoS článku
000600548100001
EID výsledku v databázi Scopus
2-s2.0-85098860353